Conversely, CD200−/− mice have been shown to display myeloid cell dysregulation, enhanced susceptibility to experimental autoimmune encephalomyelitis [28], and microglial activation [29]. The gene discussed is CD200; the disease is experimental autoimmune encephalomyelitis.